RedHill Biopharma Ltd. announced that on June 4, 2024 Ms. Alla Felder submitted to the board of directors a notice of resignation from her position as a member of the Board, effective June 6, 2024. Ms. Felder?s resignation from the Board is due to personal reasons and not as a result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3721 USD | -2.31% |
|
-5.29% | -74.51% |
06-06 | RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board | CI |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
1st Jan change | Capi. | |
---|---|---|
-74.51% | 11.86M | |
+2.97% | 94.74B | |
-4.08% | 37.28B | |
-13.26% | 32.68B | |
+74.46% | 27.72B | |
-11.58% | 16.19B | |
-1.66% | 13.88B | |
-11.67% | 11.58B | |
+190.36% | 10.92B | |
-52.61% | 9.54B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board